Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

28 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   4-methylpyrazole   Fomepizole   D00707   [3] ADH1A, ADH1B, ADH1C   [8] Chemical carcinogenesis, Drug metabolism - cytochrome P450, Fatty acid degradation, Glycolysis / Gluconeogenesis, Metabolic pathways, Metabolism of xenobiotics by cytochrome P450, Retinol metabolism, Tyrosine metabolism   [1]
301 
 2   Acu-4429   -   -   -   -   [1]
301 
 3   Alk-001   -   -   -   -   [1]
301 
 4   Alk-001 (no generic name)   -   -   -   -   [1]
301 
 5   Antioxidants   -   -   -   -   [4]
90,
298,
301,
310 
 6   Arc1905   -   -   -   -   [1]
301 
 7   Arc1905 20 mg/ml   -   -   -   -   [1]
301 
 8   Avacincaptad pegol   Avacincaptad pegol   -   -   -   [1]
301 
 9   Cholesterol   Cholesterol   D00040   -   -   [7]
19,
90,
160,
259,
261,
301,
310 
 10   Docosahexaenoic acid   Doconexent   -   -   -   [7]
6,
49,
90,
94,
240,
299,
301 
 11   Docosahexaenoic acid (dha) dietary supplement   Doconexent   -   -   -   [1]
301 
 12   Emixustat   Emixustat   D10348   -   -   [1]
301 
 13   Emixustat hydrochloride   Emixustat   D10348   -   -   [1]
301 
 14   Emixustat hydrochloride (acu-4429)   Emixustat   D10348   -   -   [1]
301 
 15   Hesc-rpe   -   -   -   -   [1]
301 
 16   Interferon gamma-1b   -   -   -   -   [7]
65,
85,
90,
228,
299,
301,
326 
 17   Lentiviral vector containing abca4 gene   -   -   -   -   [1]
301 
 18   Ma09-hrpe   -   -   -   -   [1]
301 
 19   Madeos   -   -   -   -   [1]
301 
 20   Over the counter dha/epa dietary supplementation   -   -   -   -   [1]
301 
 21   Ranibizumab   Ranibizumab   D05697   [1] VEGFA   [21] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway   [4]
34,
166,
227,
301 
 22   Ranibizumab injection (0.5 mg)   Ranibizumab   D05697   [1] VEGFA   [21] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway   [2]
166,
301 
 23   Saffron supplementation   -   -   -   -   [1]
301 
 24   Sar422459   -   -   -   -   [1]
301 
 25   Sar422459 administered in previous study tdu13583   -   -   -   -   [1]
301 
 26   Stem/progenitor cells transplantation   -   -   -   -   [2]
90,
301 
 27   Vett lentiviral con gene abca4   -   -   -   -   [1]
301 
 28   Zimura   -   -   -   -   [1]
301 

Back to top